14-56580030-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_017799.4(TMEM260):c.116T>A(p.Val39Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,250,444 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V39A) has been classified as Uncertain significance.
Frequency
Consequence
NM_017799.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM260 | NM_017799.4 | c.116T>A | p.Val39Glu | missense_variant | 1/16 | ENST00000261556.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM260 | ENST00000261556.11 | c.116T>A | p.Val39Glu | missense_variant | 1/16 | 2 | NM_017799.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000169 AC: 4AN: 23664Hom.: 0 AF XY: 0.000174 AC XY: 2AN XY: 11468
GnomAD4 exome AF: 0.000179 AC: 197AN: 1098268Hom.: 0 Cov.: 30 AF XY: 0.000187 AC XY: 97AN XY: 519128
GnomAD4 genome AF: 0.000184 AC: 28AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74350
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.116T>A (p.V39E) alteration is located in exon 1 (coding exon 1) of the TMEM260 gene. This alteration results from a T to A substitution at nucleotide position 116, causing the valine (V) at amino acid position 39 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at